Thus, the assessment of PD-L1/L2 expression in TIICs in our cohort may be beneficial in providing new insights into the utility of the PD-1 and PD-L1/L2 pathway in the prediction of GC prognosis. The gene discussed is CD274; the disease is gastric cancer.